UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (69) 69
life sciences & biomedicine (60) 60
humans (48) 48
oncology (47) 47
chemotherapy (41) 41
female (41) 41
middle aged (32) 32
aged (31) 31
male (31) 31
cancer (29) 29
gemcitabine (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (23) 23
metastasis (23) 23
adult (22) 22
treatment outcome (22) 22
deoxycytidine - analogs & derivatives (19) 19
cisplatin (17) 17
pancreatic cancer (17) 17
deoxycytidine - administration & dosage (16) 16
patients (16) 16
prognosis (16) 16
aged, 80 and over (15) 15
cancer therapies (14) 14
breast cancer (12) 12
care and treatment (12) 12
research (12) 12
lung neoplasms - drug therapy (11) 11
medicine & public health (11) 11
paclitaxel (11) 11
antimitotic agents (10) 10
antineoplastic agents (10) 10
bevacizumab (10) 10
carboplatin (10) 10
medical prognosis (10) 10
neoplasm staging (10) 10
pancreatic neoplasms - drug therapy (10) 10
survival rate (10) 10
tumors (10) 10
biological sciences (9) 9
carcinoma, non-small-cell lung - drug therapy (9) 9
clinical trials (9) 9
folfirinox (9) 9
gemcitabine plus nab-paclitaxel (9) 9
lung cancer (9) 9
multidisciplinary sciences (9) 9
neoplasm metastasis (9) 9
pancreatic neoplasms - pathology (9) 9
pnas plus (9) 9
science & technology - other topics (9) 9
therapy (9) 9
antineoplastic combined chemotherapy protocols - administration & dosage (8) 8
cancer patients (8) 8
cisplatin - administration & dosage (8) 8
follow-up studies (8) 8
lung cancer, non-small cell (8) 8
oncology, experimental (8) 8
studies (8) 8
survival analysis (8) 8
toxicity (8) 8
adenocarcinoma - drug therapy (7) 7
analysis (7) 7
carcinoma, non-small-cell lung - pathology (7) 7
drug therapy (7) 7
lung neoplasms - pathology (7) 7
metastases (7) 7
nab-paclitaxel plus gemcitabine (7) 7
overall survival (7) 7
paclitaxel - administration & dosage (7) 7
pemetrexed (7) 7
quality of life (7) 7
retrospective studies (7) 7
surgery (7) 7
adjuvant treatment (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
bladder cancer (6) 6
docetaxel (6) 6
doxorubicin (6) 6
etoposide (6) 6
gemcitabine plus cisplatin (6) 6
gene expression (6) 6
neutropenia (6) 6
organoplatinum compounds - administration & dosage (6) 6
pharmacology & pharmacy (6) 6
phase-iii trial (6) 6
survival (6) 6
adenocarcinoma - pathology (5) 5
breast neoplasms - drug therapy (5) 5
development and progression (5) 5
diagnosis (5) 5
disease-free survival (5) 5
dosage and administration (5) 5
drugs (5) 5
epirubicin (5) 5
erlotinib (5) 5
gastroenterology & hepatology (5) 5
hematology (5) 5
hematology, oncology and palliative medicine (5) 5
lung neoplasms - mortality (5) 5
medicine (5) 5
metastatic pancreatic cancer (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 08/2015, Volume 121, Issue 15, pp. 2586 - 2593
Journal Article
British journal of cancer, ISSN 1532-1827, 09/2015, Volume 113, Issue 7, pp. 989 - 995
Journal Article
Oncology letters, ISSN 1792-1074, 07/2016, Volume 12, Issue 1, pp. 727 - 730
...). Previously nab-paclitaxel plus gemcitabine has been demonstrated to improve the overall survival rate in patients with advanced pancreatic cancer with a good PS... 
Palliative therapy | Pancreatic adenocarcinoma | Tolerance | Poor performance status | CA19-9 | Nab-paclitaxel plus gemcitabine | Life Sciences & Biomedicine | Oncology | Science & Technology
Journal Article
Medicine (Baltimore), ISSN 0025-7974, 09/2020, Volume 99, Issue 39, pp. e22250 - e22250
It is unclear whether the use of antibiotics is related to the efficacy of gemcitabine plus nab-paclitaxel (GnP... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antimitotic agents | Beta lactam antibiotics | Usage | Antineoplastic agents | Pancreatic cancer | Index Medicus | Abridged Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 07/2011, Volume 22, Issue 7, pp. 1520 - 1527
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 07/2017, Volume 80, Issue 1, pp. 209 - 215
Journal Article
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], ISSN 1424-3903, 10/2018, Volume 18, Issue 7, pp. 841 - 845
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 3/2018, Volume 81, Issue 3, pp. 461 - 468
To determine the recommended dose (RD) of gemcitabine (GEM) plus S-1 (GS) in curatively resected biliary tract cancer (BTC... 
Adjuvant chemotherapy | Medicine & Public Health | Biliary tract cancer | Gemcitabine plus S-1 | Phase I study | Oncology | Cancer Research | Pharmacology/Toxicology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Antimetabolites, Antineoplastic - pharmacokinetics | Humans | Male | Drug Monitoring - methods | Antimetabolites, Antineoplastic - administration & dosage | Dose-Response Relationship, Drug | Deoxycytidine - pharmacokinetics | Biliary Tract Surgical Procedures - methods | Deoxycytidine - adverse effects | Female | Oxonic Acid - pharmacokinetics | Biliary Tract Neoplasms - drug therapy | Biliary Tract Neoplasms - pathology | Drug Administration Schedule | Deoxycytidine - administration & dosage | Tegafur - adverse effects | Drug-Related Side Effects and Adverse Reactions - etiology | Treatment Outcome | Oxonic Acid - administration & dosage | Tegafur - pharmacokinetics | Biliary Tract Neoplasms - surgery | Oxonic Acid - adverse effects | Administration, Intravenous | Maximum Tolerated Dose | Chemotherapy, Adjuvant - methods | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Tegafur - administration & dosage | Aged | Deoxycytidine - analogs & derivatives | Drug Combinations | Drug-Related Side Effects and Adverse Reactions - diagnosis | Antimitotic agents | Cancer patients | Care and treatment | Surgery | Oncology, Experimental | Adjuvant treatment | Research | Antineoplastic agents | Cancer | Biliary tract | Chemotherapy | Gemcitabine | Toxicity | Design standards | Patients | Survival | Neutropenia | Index Medicus
Journal Article
Expert review of clinical pharmacology, ISSN 1751-2433, 10/2017, Volume 10, Issue 10, pp. 1153 - 1160
.... Little is known about the treatment patterns and healthcare costs among mPC patients who initiated first-line gemcitabine plus nanoparticle albumin-bound paclitaxel (nab-P + G) and FOLFIRINOX. Methods: The MarketScan... 
gemcitabine plus nanoparticle albumin-bound paclitaxel | FOLFIRINOX | real-world data | Economic burden | metastatic pancreatic cancer | treatment patterns | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Drug Costs | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Granulocyte Colony-Stimulating Factor - economics | Humans | Middle Aged | Fluorouracil - economics | Antiemetics - administration & dosage | Cost of Illness | Male | Filgrastim | Leucovorin - economics | Pancreatic Neoplasms - drug therapy | Camptothecin - economics | Fluorouracil - therapeutic use | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Time Factors | Pancreatic Neoplasms - economics | Antineoplastic Combined Chemotherapy Protocols - economics | Camptothecin - administration & dosage | Female | Leucovorin - therapeutic use | Retrospective Studies | Paclitaxel - administration & dosage | Camptothecin - analogs & derivatives | Camptothecin - therapeutic use | Polyethylene Glycols | Deoxycytidine - administration & dosage | Pancreatic Neoplasms - pathology | Albumins - administration & dosage | Recombinant Proteins - administration & dosage | Recombinant Proteins - economics | Health Care Costs | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antiemetics - economics | Organoplatinum Compounds - economics | Aged | Organoplatinum Compounds - therapeutic use | Deoxycytidine - analogs & derivatives | Cohort Studies | Granulocyte Colony-Stimulating Factor - administration & dosage
Journal Article
Journal Article
Journal Article